Kucinski Keith A 4
4 · Matinas BioPharma Holdings, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Kucinski Keith A
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2020-01-01+350,000→ 350,000 totalExercise: $2.27Exp: 2030-01-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021.